US Pharmacopeia signs international agreements
This article was originally published in SRA
As part of its efforts to improve the quality of medicines worldwide, the US Pharmacopeial Convention has entered into agreements with a number of international partners, including China, Russia and nine countries belonging to the Association of Southeast Asian Nations.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.